GAbapentin in Paediatric Pain. Toward new therapies to challenge chronic pain in children
Penta is responsible for scientific coordination of the European Commission FP7 programme funded GAPP project.
This project on gabapentin for the treatment of paediatric chronic neuropathic pain includes development of an age-appropriate formulation and design and implementation of two randomised, comparator- controlled clinical trials and a bridging-modelling study to extrapolate results to younger children.
For more information click here
This project has received funding from the European Union’s 7th FP for research, technological development and demonstration under Grant Agreement n. 602962.